Global Hemorrhoids Treatment Market Size By Type of Treatment, By Route of Administration, By Distribution Channel, By Geographic Scope And Forecast
Published on: 2024-08-08 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Hemorrhoids Treatment Market Size By Type of Treatment, By Route of Administration, By Distribution Channel, By Geographic Scope And Forecast
Hemorrhoids Treatment Market Size And Forecast
Hemorrhoids Treatment Market size was valued at USD 3.5 Billion in 2023 and is projected to reach USD 34.9 Billion by 2030, growing at a CAGR of 24% during the forecast period 2024-2030.
The Hemorrhoids Treatment Market refers to the global industry encompassing pharmaceuticals, medical devices, and procedures aimed at alleviating symptoms and curing hemorrhoids. Hemorrhoids, also known as piles, are swollen veins in the lower rectum and anus, causing discomfort, pain, bleeding, and itching. The market includes over-the-counter medications, prescription drugs, minimally invasive procedures, and surgical interventions designed to address various stages of hemorrhoidal disease.
Global Hemorrhoids Treatment Market Drivers
The market drivers for the Hemorrhoids Treatment Market can be influenced by various factors. These may include
- Growing Prevalence of Haemorrhoids One of the main factors propelling the market is the growing prevalence of haemorrhoids among people worldwide. The reasons behind this rise in demand for efficient therapies include ageing, chronic constipation or diarrhoea, obesity, and pregnancy.
- Lifestyle Factors Prolonged sitting, which is frequently linked to modern work environments, poor dietary choices (such as low-fiber diets), and sedentary lifestyles all play a major role in the development of haemorrhoids, which in turn drives the demand for treatment options.
- Growing Awareness and Social Acceptance As the social stigma attached to haemorrhoids is lessened and more people become aware of their treatment choices, the market is expected to rise as more individuals seek medical attention.
- Improvements in Treatment Technologies The market for haemorrhoids is growing as a result of improvements in medical treatments, such as minimally invasive surgical methods, which have made the procedure less painful and more successful.
- Better Healthcare Infrastructure Patients can seek treatment more easily when there are improvements in healthcare infrastructure and accessibility in rising economies, which supports the market’s expansion.
- Ageing Population As the world’s population ages, it is anticipated that the prevalence of illnesses like haemorrhoids, which are more common in older persons, would increase. This will increase demand for treatment options.
- Growing Healthcare Spending More money spent on healthcare by both governments and private citizens makes treatments, such as haemorrhoids, more accessible.
- Public Health Campaigns and Education By raising awareness and motivating people to seek treatment, public health initiatives and educational campaigns regarding colorectal health can support market expansion.
- Easy Access to Over-the-Counter Remedies Patients can obtain care more easily and without a prescription thanks to the availability of over-the-counter remedies for mild cases of haemorrhoids, which is good news for the market.
- Increased Research and Development Activities Proctology and related drugs are the subject of ongoing research and development, which offers novel, more effective, and frequently less intrusive treatment alternatives, drawing in a wider patient base.
Global Hemorrhoids Treatment Market Restraints
Several factors can act as restraints or challenges for the Hemorrhoids Treatment Market. These may include
- Lack of Knowledge and Social Stigma Although awareness is increasing, many communities still have a severe lack of knowledge regarding haemorrhoids. Additionally, people frequently put off seeking prompt medical advice and treatment due to the social stigma and humiliation associated with the condition.
- Preference for Over-the-Counter (OTC) goods and Home Remedies Rather than obtaining professional medical attention, a lot of people with moderate symptoms would rather utilise over-the-counter (OTC) goods or home remedies. This propensity may restrain the market for professional haemorrhoid treatments from expanding.
- expense of Treatment For some patients, particularly in nations with less extensive healthcare coverage, the expense of cutting-edge treatments, particularly surgical interventions, can be exorbitant.
- Fear of Surgery A lot of patients have anxiety related to surgery because they are afraid of the pain, the aftereffects, and the recuperation time. They may choose not to pursue possibly more beneficial surgical procedures as a result of this concern.
- Absence of Skilled Healthcare experts Patients may not have access to sophisticated treatment options in certain areas due to a lack of healthcare experts with the necessary skills to treat haemorrhoids.
- Treatment Complications and Side Effects Patients contemplating surgical haemorrhoid treatments may be discouraged by worries about the possible complications and side effects of these procedures.
- Regulatory Difficulties The regulatory environment pertaining to drugs and medical treatments can be complicated and varied greatly between jurisdictions. The lengthy and difficult procedure of obtaining clearance for new medicines might obstruct the release of creative solutions onto the market.
- Inadequate Healthcare Infrastructure in Developing locations In certain developing locations, the availability and accessibility of efficient haemorrhoid treatments may be restricted due to inadequate healthcare infrastructure and restricted access to medical facilities.
- Competition from Alternative Therapies The availability of alternative therapies, such as homoeopathy, naturopathy, and ayurvedic medicine, particularly in some cultures and areas, may pose a threat to more established haemorrhoid treatments and hence slow down the growth of the market.
- Problems with Insurance Coverage and Reimbursement Certain haemorrhoid therapies, particularly cosmetic or elective procedures, may not be covered by insurance in some countries, which may deter patients from pursuing these treatments.
Global Hemorrhoids Treatment Market Segmentation Analysis
The Global Hemorrhoids Treatment Market is Segmented on the basis of Type of Treatment, Route of Administration, Distribution Channel, and Geography.
Hemorrhoids Treatment Market, By Type of Treatment
- Medication This includes over-the-counter (OTC) drugs, creams, ointments, suppositories, and prescribed medications.
- Non-Surgical Procedures Such as rubber band ligation, sclerotherapy, infrared photocoagulation, and laser treatments.
- Surgical Procedures Including hemorrhoidectomy, stapled hemorrhoidopexy, and other minimally invasive surgical methods.
Hemorrhoids Treatment Market, By Route of Administration
- OralTablets, capsules, and other oral medications.
- TopicalCreams, ointments, gels, and suppositories applied directly to the affected area.
- Grade IV Hemorrhoids that prolapse and cannot be pushed back in; they may contain blood clots or pull much of the lining of the rectum through the anus.
Hemorrhoids Treatment Market, By Distribution Channel
- Hospital Pharmacies Pharmacies within hospitals providing medications and products for hemorrhoid treatment.
- Retail Pharmacies Including local drug stores and pharmacy chains.
- Online Pharmacies E-commerce platforms offering medications and healthcare products.
Hemorrhoids Treatment Market, By Geographic Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Key Players
The major players in the Hemorrhoids Treatment Market can be categorized into two main groups
- Bayer AG
- Pfizer Inc
- Johnson & Johnson Services, Inc
- GlaxoSmithKline plc
- AstraZeneca plc
- Medtronic
- Boston Scientific Corporation
- Olympus Corporation
- Baxter International Inc
- Cook Medical
Report Scope
REPORT ATTRIBUTES | DETAILS |
---|---|
Study Period | 2020-2030 |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Historical Period | 2020-2022 |
Unit | Value (USD Billion) |
Key Companies Profiled | Bayer AG, Pfizer Inc, Johnson & Johnson Services, Inc, GlaxoSmithKline plc, AstraZeneca plc, Medtronic, Boston Scientific Corporation, Olympus Corporation, Baxter International Inc. |
Segments Covered | By Type of Treatment, By Route of Administration, By Distribution Channel, and By Geography. |
Customization scope | Free report customization (equivalent to up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Analyst’s Take
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.